The impact of selective serotonin reuptake inhibitors on the risk of intracranial haemorrhage: A systematic review and meta-analysis.

Selective serotonin reuptake inhibitor haemorrhagic stroke intracranial haemorrhage meta-analysis systematic review

Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 15 08 2018
accepted: 08 01 2019
entrez: 2 7 2019
pubmed: 2 7 2019
medline: 2 7 2019
Statut: ppublish

Résumé

Observational studies have suggested increased risk of intracranial haemorrhage (ICrH) in patients receiving selective serotonin reuptake inhibitors (SSRIs). We sought to clarify the impact of SSRIs on ICrH, accounting for study methodology. A comprehensive search of Medline, Embase and the Cochrane Library from 1960 to December 2017 identified studies comparing SSRIs with control. The outcomes (first-ever and recurrent ICrH) were meta-analysed using a random effects model. Twenty-four observational studies and three randomised trials were available for meta-analysis, totalling 4,844,090 patient-years of follow-up. Those receiving SSRIs were more likely to be female ( Although SSRIs are associated with an increased risk of ICrH, the association is partly accounted for by important biases and other methodological limitations in the available observational data. Our findings suggest there is insufficient high-quality data to advise restriction of SSRIs because of concern regarding ICrH risk.

Identifiants

pubmed: 31259262
doi: 10.1177/2396987319827211
pii: 10.1177_2396987319827211
pmc: PMC6591760
doi:

Types de publication

Journal Article

Langues

eng

Pagination

144-152

Références

Br J Clin Pharmacol. 2000 Jul;50(1):43-7
pubmed: 10886117
Stroke. 2002 Jun;33(6):1465-73
pubmed: 12052976
Acta Psychiatr Scand. 1992 Aug;86(2):138-45
pubmed: 1529737
CNS Drugs. 2006;20(2):143-51
pubmed: 16478289
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):836-40
pubmed: 17220294
Stroke. 2007 Nov;38(11):3049-51
pubmed: 17901378
Ann Pharmacother. 2008 Feb;42(2):177-84
pubmed: 18212255
Arch Intern Med. 2008 Jan 28;168(2):180-5
pubmed: 18227365
Cerebrovasc Dis. 2008;26(3):266-71
pubmed: 18648199
Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):196-202
pubmed: 19115419
Pharmacoepidemiol Drug Saf. 2009 May;18(5):412-6
pubmed: 19301238
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Ann Med. 2009;41(8):619-28
pubmed: 19711211
Arch Intern Med. 2009 Dec 14;169(22):2128-39
pubmed: 20008698
Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):722-30
pubmed: 20582908
Clin Pharmacol Ther. 2011 Jan;89(1):89-96
pubmed: 21107313
Br J Clin Pharmacol. 2011 Jan;71(1):116-20
pubmed: 21143507
Am J Psychiatry. 2011 May;168(5):511-21
pubmed: 21406464
Stroke. 2011 Oct;42(10):2770-5
pubmed: 21836097
JAMA. 2011 Sep 21;306(11):1241-9
pubmed: 21934057
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Neurology. 2012 Oct 30;79(18):1862-5
pubmed: 23077009
Cochrane Database Syst Rev. 2012 Nov 14;11:CD009286
pubmed: 23152272
Stroke. 2013 Feb;44(2):420-6
pubmed: 23306326
Stroke. 2013 Mar;44(3):585-90
pubmed: 23329207
J Clin Epidemiol. 2013 Apr;66(4):408-14
pubmed: 23337781
Am J Geriatr Psychiatry. 2013 Aug;21(8):811-5
pubmed: 23567390
Am J Geriatr Psychiatry. 2013 Sep;21(9):855-62
pubmed: 23930743
J Neurol. 2014 Apr;261(4):686-95
pubmed: 24477492
Stroke. 2014 Jul;45(7):2121-3
pubmed: 24893612
Am J Cardiol. 2014 Aug 15;114(4):583-6
pubmed: 25001151
Int J Stroke. 2014 Oct;9(7):840-55
pubmed: 25156220
BMC Neurol. 2015 Jun 05;15:86
pubmed: 26045186
Int J Evid Based Healthc. 2015 Sep;13(3):132-40
pubmed: 26360830
J Stroke Cerebrovasc Dis. 2016 Apr;25(4):761-70
pubmed: 26823037
Restor Neurol Neurosci. 2016;34(2):177-87
pubmed: 26923613
J Head Trauma Rehabil. 2017 Jan/Feb;32(1):E42-E49
pubmed: 27022963
Stroke. 2016 Jun;47(6):e98-e169
pubmed: 27145936
PLoS One. 2016 Nov 10;11(11):e0166223
pubmed: 27832176
JAMA Neurol. 2017 Feb 1;74(2):173-180
pubmed: 27918771
Stroke. 2017 Feb;48(2):e30-e43
pubmed: 27932603
Lancet Psychiatry. 2017 Jan;4(1):33-41
pubmed: 28012485
BMC Psychiatry. 2017 Feb 8;17(1):58
pubmed: 28178949
J Clin Psychiatry. 2017 Sep/Oct;78(8):e1006-e1012
pubmed: 28994901
Stroke. 2017 Dec;48(12):3239-3244
pubmed: 29127269
Int J Stroke. 2018 Jul;13(5):511-517
pubmed: 29134925
J Stroke Cerebrovasc Dis. 2018 May;27(5):1178-1189
pubmed: 29276014
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Psychosomatics. 1996 Jan-Feb;37(1):12-6
pubmed: 8600488
JAMA. 1998 Nov 18;280(19):1690-1
pubmed: 9832001

Auteurs

Melanie P Jensen (MP)

Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.

Oliver J Ziff (OJ)

Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.

Gargi Banerjee (G)

Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.

Gareth Ambler (G)

Department of Statistical Science, UCL, London, UK.

David J Werring (DJ)

Stroke Research Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.

Classifications MeSH